We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LXFR:NYSELuxfer Holdings PLC Analysis

Data as of 2026-05-23 - not real-time

$16.23

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Luxfer Holdings PLC is trading firmly above its short‑term moving averages, with the 20‑day and 50‑day SMAs both lagging the current price, reinforcing a bullish technical backdrop. The RSI sits in the high‑60s, suggesting strong momentum but edging toward overbought territory, while the MACD line has just nudged above its signal, confirming a bullish bias.
Fundamentally, the stock appears stretched: a trailing PE of nearly 39 versus an industry average of 30, a price‑to‑book near 2×, and a DCF‑derived fair value well below the market price indicate overvaluation. Revenue is contracting, margins are modest, and the dividend payout exceeds earnings, raising concerns about dividend sustainability. Nonetheless, the company benefits from a solid dividend yield of about 3 % and a recent analyst upgrade to a strong‑buy, which, combined with a modest upside potential relative to the current price, keeps the stock in focus for opportunistic investors.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Technical momentum remains strong with price above key moving averages
  • Analyst upgrade to strong‑buy and recent positive coverage
  • Short‑interest remains low, limiting downside pressure

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Potential for earnings improvement as the turnaround in the Elektron segment materializes
  • Attractive dividend yield if payout can be re‑aligned to cash flow
  • Upside potential indicated by analyst price targets above current levels

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Valuation remains stretched relative to fundamentals
  • Revenue contraction and high payout ratio limit long‑term growth confidence
  • Exposure to cyclical industrial demand and regulatory environments adds uncertainty

Key Metrics & Analysis

Financial Health

Revenue Growth-13.50%
Profit Margin1.56%
P/E Ratio38.6
ROE5.06%
ROA5.85%
Debt/Equity30.78
P/B Ratio1.9
Op. Cash Flow$24.5M
Free Cash Flow$23.7M
Industry P/E29.7

Technical Analysis

TrendBullish
RSI69.7
Support$13.02
Resistance$16.38
MA 20$15.23
MA 50$13.56
MA 200$13.55
MACDBullish
VolumeStable
Fear & Greed Index91.61

Valuation

Fair Value$9.41
Target Price$20.50
Upside/Downside26.31%
GradeOvervalued
TypeValue
Dividend Yield3.20%

Risk Assessment

Beta1.41
Volatility37.40%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.